Vaxess
PrivateLast Round
Series C
Mar 25, 2026
Total Funding Raised
$138.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vaxess Technologies is a biotechnology company that develops proprietary microarray patch technology for the sustained, needle-free, and refrigeration-free delivery of vaccines and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxess Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vaxess Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 25, 2026 | ||||
| Early Funding | Apr 9, 2025 | ||||
| VC Round | May 22, 2024 | ||||
| Early Funding | Sep 13, 2023 | ||||
| Series B Extension | Jan 10, 2023 | ||||
Series B | Nov 2, 2022 |
Vaxess Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| RA Capital Management | Early Funding, VC Round, Series B Extension, Series B, Series C |
| The Engine | Series B, Early Funding, Series B Extension, Series A |
| Engine Ventures | Series B, Early Funding, Series C, VC Round, Series A |
| NIH RADx | Grant |
| BioInnovation Capital | Series A, Series B Extension |
| Massachusetts Life Sciences Center | Debt, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$50M Series C round raised.
- Jan 1, 2026
Supporting Phase 2 and Phase 3 clinical manufacturing.
Vaxess Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vaxess's valuation, stock price, and market status.